In the Matter of Certain Modified Vaccinia Ankara (“MVA”) Viruses and Vaccines and Pharmaceutical Compositions Based Thereon; Notice of a Commission Determination Not To Review an Initial Determination Terminating the Investigation in Its Entirety Based on a Consent Order; Issuance of Consent Order, 50978 [E7-17465]

Download as PDF 50978 Federal Register / Vol. 72, No. 171 / Wednesday, September 5, 2007 / Notices Dated: August 10, 2007. Michael L. Carpenter, Senior Permit Biologist, Branch of Permits, Division of Management Authority. [FR Doc. E7–17502 Filed 9–4–07; 8:45 am] BILLING CODE 4310–55–P INTERNATIONAL TRADE COMMISSION [Investigation No. 337–TA–550] In the Matter of Certain Modified Vaccinia Ankara (‘‘MVA’’) Viruses and Vaccines and Pharmaceutical Compositions Based Thereon; Notice of a Commission Determination Not To Review an Initial Determination Terminating the Investigation in Its Entirety Based on a Consent Order; Issuance of Consent Order U.S. International Trade Commission. ACTION: Notice. rfrederick on PROD1PC67 with NOTICES AGENCY: SUMMARY: Notice is hereby given that the U.S. International Trade Commission has determined not to review an initial determination (‘‘ID’’) (Order No. 54) of the presiding administrative law judge (‘‘ALJ’’) in the above-captioned investigation terminating the investigation in its entirety on the basis of a consent order. FOR FURTHER INFORMATION CONTACT: Clint A. Gerdine, Office of the General Counsel, U.S. International Trade Commission, 500 E Street, SW., Washington, DC 20436, telephone (202) 708–2310. Copies of non-confidential documents filed in connection with this investigation are or will be available for inspection during official business hours (8:45 a.m. to 5:15 p.m.) in the Office of the Secretary, U.S. International Trade Commission, 500 E Street, SW., Washington, DC 20436, telephone (202) 205–2000. General information concerning the Commission may also be obtained by accessing its Internet server (http://www.usitc.gov). The public record for this investigation may be viewed on the Commission’s electronic docket (EDIS) at http:// edis.usitc.gov. Hearing-impaired persons are advised that information on this matter can be obtained by contacting the Commission’s TDD terminal on (202) 205–1810. SUPPLEMENTARY INFORMATION: This investigation was instituted on September 23, 2005, based on a complaint filed by Bavarian Nordic A/S of Denmark (‘‘Bavarian Nordic’’). The complaint alleged violations of section 337 of the Tariff Act of 1930 (19 U.S.C. 1337) (‘‘section 337’’) in the VerDate Aug<31>2005 13:51 Sep 04, 2007 Jkt 211001 importation into the United States, the sale for importation, and the sale within the United States after importation of certain Modified Vaccinia Ankara (‘‘MVA’’) viruses and vaccines and pharmaceutical compositions based thereon by reason of infringement of various claims of United States Patent Nos. 6,761,893 and 6,913,752. The complaint also alleged violations of section 337 in the importation of certain MVA viruses and vaccines and pharmaceutical compositions based thereon or in the sale of such articles by reason of misappropriation of trade secrets, the threat or effect of which is to destroy or substantially injure an industry in the United States. The complaint named a single respondent, Acambis PLC of the United Kingdom (‘‘Acambis’’). Only the patent allegations remain in this investigation. After a hearing and post-hearing briefing, the then-presiding ALJ issued a final initial determination (‘‘final ID’’) on September 6, 2006, finding no violation of section 337. The ALJ held that the patents were infringed but invalid. Bavarian Nordic, Acambis, and the Commission investigative attorney filed petitions for review of the final ID. On November 22, 2006, the Commission determined to review the final ID in its entirety, and to ask the parties for briefing on the issues on review and on remedy, the public interest, and bonding. On February 21, 2007, the Commission determined to remand the final ID to the ALJ and to extend the target date for completion of the investigation to October 19, 2007. The target date was subsequently extended to February 20, 2008. On July 27, 2007, complainant and respondent filed a joint motion to terminate the investigation on the basis of a consent order. The Commission investigative attorney filed a response in support of the motion. The consent order includes a provision vacating the final ID of September 6, 2006. The ALJ issued the subject ID on August 9, 2007, granting the motion for termination. He found that the consent order stipulation satisfies Commission rule 210.21(c)(3)(i), and that the termination of the investigation by consent order is not contrary to the public interest. No party petitioned for review of the ID. The Commission has determined not to review the ID. The investigation is terminated in its entirety and the final ID of September 6, 2006, is vacated. The authority for the Commission’s determination is contained in section 337 of the Tariff Act of 1930, as amended (19 U.S.C. 1337), and in PO 00000 Frm 00048 Fmt 4703 Sfmt 4703 sections 210.21(c) and 210.42(h) of the Commission’s Rules of Practice and Procedure (19 CFR 210.21(c), 210.42(h)). Issued: August 29, 2007. By order of the Commission. Marilyn R. Abbott, Secretary to the Commission. [FR Doc. E7–17465 Filed 9–4–07; 8:45 am] BILLING CODE 7020–02–P INTERNATIONAL TRADE COMMISSION [Investigation No. 337–TA–577] In the Matter of Certain Wireless Communications Equipment, Articles Therein, and Products Containing the Same; Notice of Commission Decision Not To Review an Initial Determination Terminating the Investigation Based on Settlement U.S. International Trade Commission. ACTION: Notice. AGENCY: SUMMARY: Notice is hereby given that the U.S. International Trade Commission has determined not to review an initial determination (‘‘ID’’) (Order No. 59) issued by the presiding administrative law judge (‘‘ALJ’’) terminating the above-captioned investigation based on a settlement agreement. FOR FURTHER INFORMATION CONTACT: Paul M. Bartkowski, Esq., Office of the General Counsel, U.S. International Trade Commission, 500 E Street, SW., Washington, DC 20436, telephone (202) 708–5432. Copies of non-confidential documents filed in connection with this investigation are or will be available for inspection during official business hours (8:45 a.m. to 5:15 p.m.) in the Office of the Secretary, U.S. International Trade Commission, 500 E Street, SW., Washington, DC 20436, telephone (202) 205–2000. General information concerning the Commission may also be obtained by accessing its Internet server at http://www.usitc.gov. The public record for this investigation may be viewed on the Commission’s electronic docket (EDIS) at http:// edis.usitc.gov. Hearing-impaired persons are advised that information on this matter can be obtained by contacting the Commission’s TDD terminal on (202) 205–1810. SUPPLEMENTARY INFORMATION: This investigation was instituted on June 29, 2006, based on a complaint filed by Samsung Telecommunications America, LLP and Samsung Electronics Co., Ltd. (‘‘Complainants’’). The complaint alleged violations of section 337 of the E:\FR\FM\05SEN1.SGM 05SEN1

Agencies

[Federal Register Volume 72, Number 171 (Wednesday, September 5, 2007)]
[Notices]
[Page 50978]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: E7-17465]


=======================================================================
-----------------------------------------------------------------------

INTERNATIONAL TRADE COMMISSION

[Investigation No. 337-TA-550]


In the Matter of Certain Modified Vaccinia Ankara (``MVA'') 
Viruses and Vaccines and Pharmaceutical Compositions Based Thereon; 
Notice of a Commission Determination Not To Review an Initial 
Determination Terminating the Investigation in Its Entirety Based on a 
Consent Order; Issuance of Consent Order

AGENCY: U.S. International Trade Commission.

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: Notice is hereby given that the U.S. International Trade 
Commission has determined not to review an initial determination 
(``ID'') (Order No. 54) of the presiding administrative law judge 
(``ALJ'') in the above-captioned investigation terminating the 
investigation in its entirety on the basis of a consent order.

FOR FURTHER INFORMATION CONTACT: Clint A. Gerdine, Office of the 
General Counsel, U.S. International Trade Commission, 500 E Street, 
SW., Washington, DC 20436, telephone (202) 708-2310. Copies of non-
confidential documents filed in connection with this investigation are 
or will be available for inspection during official business hours 
(8:45 a.m. to 5:15 p.m.) in the Office of the Secretary, U.S. 
International Trade Commission, 500 E Street, SW., Washington, DC 
20436, telephone (202) 205-2000. General information concerning the 
Commission may also be obtained by accessing its Internet server 
(http://www.usitc.gov). The public record for this investigation may be 
viewed on the Commission's electronic docket (EDIS) at http://
edis.usitc.gov. Hearing-impaired persons are advised that information 
on this matter can be obtained by contacting the Commission's TDD 
terminal on (202) 205-1810.

SUPPLEMENTARY INFORMATION: This investigation was instituted on 
September 23, 2005, based on a complaint filed by Bavarian Nordic A/S 
of Denmark (``Bavarian Nordic''). The complaint alleged violations of 
section 337 of the Tariff Act of 1930 (19 U.S.C. 1337) (``section 
337'') in the importation into the United States, the sale for 
importation, and the sale within the United States after importation of 
certain Modified Vaccinia Ankara (``MVA'') viruses and vaccines and 
pharmaceutical compositions based thereon by reason of infringement of 
various claims of United States Patent Nos. 6,761,893 and 6,913,752. 
The complaint also alleged violations of section 337 in the importation 
of certain MVA viruses and vaccines and pharmaceutical compositions 
based thereon or in the sale of such articles by reason of 
misappropriation of trade secrets, the threat or effect of which is to 
destroy or substantially injure an industry in the United States. The 
complaint named a single respondent, Acambis PLC of the United Kingdom 
(``Acambis''). Only the patent allegations remain in this 
investigation.
    After a hearing and post-hearing briefing, the then-presiding ALJ 
issued a final initial determination (``final ID'') on September 6, 
2006, finding no violation of section 337. The ALJ held that the 
patents were infringed but invalid.
    Bavarian Nordic, Acambis, and the Commission investigative attorney 
filed petitions for review of the final ID. On November 22, 2006, the 
Commission determined to review the final ID in its entirety, and to 
ask the parties for briefing on the issues on review and on remedy, the 
public interest, and bonding. On February 21, 2007, the Commission 
determined to remand the final ID to the ALJ and to extend the target 
date for completion of the investigation to October 19, 2007. The 
target date was subsequently extended to February 20, 2008.
    On July 27, 2007, complainant and respondent filed a joint motion 
to terminate the investigation on the basis of a consent order. The 
Commission investigative attorney filed a response in support of the 
motion. The consent order includes a provision vacating the final ID of 
September 6, 2006.
    The ALJ issued the subject ID on August 9, 2007, granting the 
motion for termination. He found that the consent order stipulation 
satisfies Commission rule 210.21(c)(3)(i), and that the termination of 
the investigation by consent order is not contrary to the public 
interest. No party petitioned for review of the ID. The Commission has 
determined not to review the ID. The investigation is terminated in its 
entirety and the final ID of September 6, 2006, is vacated.
    The authority for the Commission's determination is contained in 
section 337 of the Tariff Act of 1930, as amended (19 U.S.C. 1337), and 
in sections 210.21(c) and 210.42(h) of the Commission's Rules of 
Practice and Procedure (19 CFR 210.21(c), 210.42(h)).

     Issued: August 29, 2007.

    By order of the Commission.
Marilyn R. Abbott,
Secretary to the Commission.
 [FR Doc. E7-17465 Filed 9-4-07; 8:45 am]
BILLING CODE 7020-02-P